Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.

null nullPeter HorbyMarion MafhamLouise LinsellJennifer L BellNatalie StaplinJonathan R EmbersonMartin WiselkaAndrew UstianowskiEinas ElmahiBenjamin PrudonTony WhitehouseTimothy FeltonJohn WilliamsJakki FaccendaJonathan UnderwoodJ Kenneth BaillieLucy C ChappellSaul N FaustThomas JakiKatie JefferyWei Shen LimAlan MontgomeryKathryn RowanJoel TarningJames A WatsonNicholas J WhiteEdmund JuszczakRichard HaynesMartin J Landray

Published in: The New England journal of medicine (2020)

Among patients hospitalized with Covid-19, those who received hydroxychloroquine did not have a lower incidence of death at 28 days than those who received usual care. (Funded by UK Research and Innovation and National Institute for Health Research and others; RECOVERY ISRCTN number, ISRCTN50189673; ClinicalTrials.gov number, NCT04381936.).

Keyphrases

quality improvement
coronavirus disease
sars cov
healthcare
palliative care
risk factors
cross sectional
pain management
affordable care act
respiratory syndrome coronavirus
chronic pain
health insurance